Mirae Asset Global Investments
GPCR icon

Mirae Asset Global Investments’s Structure Therapeutics GPCR Stock Holding History

Mirae Asset Global Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Sell
5,107
-1,304
-20% -$57.7K ﹤0.01% 1072
2026
Q1 		$309K Buy
6,411
+1,144
+22% +$78.3K ﹤0.01% 1009
2025
Q4 		$366K Buy
5,267
+1,211
+30% +$49.4K ﹤0.01% 1053
2025
Q3 		$114K Sell
4,056
-64
-2% -$1.27K ﹤0.01% 1189
2025
Q2 		$85.4K Buy
4,120
+435
+12% +$9.56K ﹤0.01% 1163
2025
Q1 		$72.9K Buy
3,685
+119
+3% +$2.92K ﹤0.01% 1169
2024
Q4 		$99.7K Sell
3,566
-218
-6% -$7.74K ﹤0.01% 1145
2024
Q3 		$158K Buy
3,784
+1,420
+60% +$54.9K ﹤0.01% 1128
2024
Q2 		$92.5K Buy
+2,364
New +$97.1K ﹤0.01% 1152

Other funds holding GPCR

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments's GPCR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Structure Therapeutics (GPCR) stake by 20% in Q2 2026, selling an estimated $57.7K and leaving 5,107 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Mirae Asset Global Investments first reported a position in GPCR in Q2 2024 and has held it in 9 quarters since. The position peaked at $366K in Q4 2025. 60 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Mirae Asset Global Investments held 5,107 shares of Structure Therapeutics worth $274K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,304 Structure Therapeutics shares in Q2 2026, an estimated $57.7K.
  • Structure Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1072 holding.
  • Mirae Asset Global Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Structure Therapeutics position peaked at $366K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.